| |
| |
| |
|
A one-day international summit on innovation, clinical benefits & cost. | View Online
|
|
|
| |
|
| |
| |
| |
A One-Day International Summit
on Innovation, Clinical Benefits & Cost |
| |
| Featuring Round Table Discussions with Expert Panelists Hosted by Moderators |
| |
|
|
|
| |
|
|
|
| |
| Meet the Speakers/Panelists |
|
| |
| |
|
| |
ALEXANDER
EGGERMONT
|
| |
MD, PhD, Director Gustave Roussy; Chairman, Cancer
Core Europe
|
|
|
|
| |
MACE
ROTHENBERG
|
| |
|
MD, Chief Development Officer, Oncology Global Product Development, Pfizer, Inc
|
|
|
|
| |
MAUREEN
SULLIVAN
|
| |
|
Chief Strategy and Innovation Officer, Blue Cross Blue Shield Association
|
|
|
|
| |
|
CLIFFORD HUDIS
|
| |
MD, Chief
Executive Officer,
American Society
of Clinical
Oncology (ASCO)
|
|
|
| |
|
| |
|
JAMES GULLEY
|
| |
|
MD, PhD,
Chief, GU Malignancies Branch and Head, Immunotherapy Group, GMB;
Dir., Medical Oncology Services, Center for Cancer Research,
NCI, NIH
|
|
|
|
| |
ROBERT
BAZELL
|
| |
|
Adjunct Professor of Molecular, Cellular and Developmental Biology, Yale University; Former Chief Science and Health Correspondent, NBC News
|
|
|
|
| |
JEFFREY
LE BENGER
|
| |
MD, Chairman and
CEO, Summit Medical
Group & Summit
Health Management
|
|
|
|
| |
MICHEL
SADELAIN
|
| |
|
MD, PhD, Director, Center for Cell Engineering Memorial Sloan Kettering Cancer Center |
|
|
| |
|
| |
|
PETER FINE
|
| |
|
President and CEO, Banner Health
|
|
|
|
| |
MARYANN
CHRISTOPHER
|
| |
|
MSN, VP, Clinical Operations and Transformation, Horizon Blue Cross Blue Shield of New Jersey
|
|
|
|
| |
STEPHEN
EMERSON
|
| |
|
MD, PhD, Former Director, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center
|
|
|
|
| |
WILLIAM
HENRICH
|
| |
|
MD, President and Professor of Medicine, UT Health San Antonio
|
|
|
| |
|
| |
|
GRACE STUNTZ
|
| |
|
Health Policy Director, Senate HELP Committee Majority Staff, US Senate
|
|
|
|
| |
RICHARD
SULLIVAN
|
| |
MD, PhD, Director, institute for Cancer Policy, King’s
College London
|
|
|
|
| |
|
GARY SCHWARTZ
|
| |
|
MD, Chief, Hematology / Oncology Division, Deputy Director, Herbert Irving Comprehensive Cancer Center, Columbia University
|
|
|
|
| |
|
MATTHEW SHAULIS
|
| |
|
President, North America Oncology, Pfizer, Inc.
|
|
|
|
|
|
| |
|
| |
|
| |
Jeffrey
L. Weber
|
| |
|
MD, PhD, Deputy Director, Perlmutter Cancer Center, NYU, Langone Medical Center
|
|
|
|
| |
GLEN
STETTIN
|
| |
|
MD, Chief Innovation Officer & Senior Vice President - Clinical, Research & New Solutions, Express Scripts
|
|
|
|
| |
|
FRAN VISCO
|
| |
|
President, National Breast Cancer Coalition
|
|
|
|
| |
|
SARAH ISELIN
|
| |
SVP and Chief Strategy Officer, GuideWell / Florida Blue
|
|
|
| |
|
| |
Michael
J. Fisch
|
| |
|
MD, MPH, Medical Director, Medical Oncology Programs and Genetics AIM Specialty Health |
|
|
|
| |
ARTHUR
CAPLAN
|
| |
|
PhD, Mitty Chair and Director, Division of Medical Ethics NYU School of Medicine |
|
|
|
| |
|
ERIC RUBIN
|
| |
|
MD, SVP and Therapeutic Area Head, Oncology Early Development Merck |
|
|
|
| |
|
DIANE MEIER
|
| |
|
MD, Director, Center to Advance Palliative Care, Mount Sinai Health System, NYC
|
|
|
|
| |
|
|
| |
OLIVIER
ELEMENTO
|
| |
|
PhD, Director, Englander Institute for Precision Medicine, Weill Cornell Medicine
|
|
|
|
| |
|
ALAN BRYCE
|
| |
|
MD, Vice Chair, Hematology & Medical Oncology and Medical Director, Genomic Oncology Clinic, Mayo Clinic Arizona
|
|
|
|
| |
JACQUE
SOKOLOV
|
| |
|
MD, Chairman and CEO, SSB Solutions
|
|
|
|
|
| |
|
|
|
| |
|
MICHAEL MEYER
|
| |
|
President, Meyer Consulting
|
|
|
|
| |
|
RYAN HUBBS
|
| |
|
Principal, Meyer Consulting
|
|
|
|
|
| |
|
|
|
| Meet The Sponsors |
|
| |
|
|
| |
| What You Will Learn |
|
|
| |
| |
| • |
The latest developments in cancer care research, delivery and cost / pricing through the lens of health plans, academic cancer centers, pharma, and providers / oncology groups and what has happened over the last 12 months. |
|
| |
|
|
|
| |
| • |
How genomics, precision medicine, immunotherapeutic and biosimilar therapies will change the future of cancer care. |
|
| |
|
|
|
|
| |
| |
| • |
The future of cancer treatment and the challenges and opportunities around genomically-driven decision making. |
|
| |
|
|
|
| |
| |
| • |
The challenges facing health plans, providers and governments in financing new innovative cancer treatments in a changing health policy environment. |
|
| |
|
|
|
|
| |
| |
| • |
New innovations and technology to improve diagnosis, integrated care, survivorship programs and palliative care. |
|
| |
|
|
|
| |
| |
| • |
The realities and challenges of innovative new cancer modalities like CAR T-Cell Therapy. |
|
| |
|
|
|
|
| |
| |
| • |
New partnerships being formed to facilitate innovation. |
|
| |
|
|
|
| |
| |
| • |
The impact of these new innovations on patients and families and how they are being reported in the media. |
|
| |
|
|
|
|
| |
| |
| • |
The use of large data and analytics to improve outcomes and reduce cost.
|
|
| |
|
|
|
| |
| • |
What's getting in our way of moving forward in these areas. |
|
| |
|
|
|
|
|
|
| |
| About The Organizer |
|
|
| |
| |
|
|
Meyer Consulting is an international health care consulting and recruiting firm that brings leading experts together in collaborative settings to build better health care solutions.
www.meyerconsultinginc.com
|
|
| |
|
|
|
|
|
|
| |
| About The Venue |
| |
|
|
| |
|
| |
The New York Genome Center is a consortium of renowned academic, medical & industry leaders across the globe, focusing on translating genomic research.
www.nygenome.org
101 Avenue of the Americas, New York, NY 10013
|
| |
|
|
|
| |
| |
| |
| Copyright © 2017 Meyer Consulting, All rights reserved. | Unsubscribe
|
| |
|
|
|
| |
|
|
|
|
